Artificial Intelligence

Semiconductor firm Aeluma will meet investors at the ROTH conference, betting its unique, scalable chip technology is the key to powering the future of AI and AR/VR.

A new collaboration is betting on tiny natural particles to deliver a gene-editing cure for a devastating neurological disorder, bypassing a key medical hurdle.

The energy giant is using a complex financial tool to fund major projects. We break down what it means for investors and the future of the power grid.

With $62B in 2025 funding and a 17% surge, Origence is arming credit unions with AI and embedded finance to compete in a rapidly changing market.

A new platform is tackling the UK's fragmented services industry with rapid verification and fixed pricing, promising to end quote delays forever.

China's discount e-tailer shows financial resilience with higher Q4 profit and a big dividend, betting on AI and its off-price model for future growth.

Montréal startup JetScale AI lands an oversubscribed seed round for its AI platform that slashes cloud spending and energy waste in just minutes.

A novel mouse model with human immune receptors promises to slash the high failure rate of antibody therapies, accelerating life-saving treatments.

Fourth iQ 3.0 launches with above-store AI, promising executives a new way to fight rising costs, boost profits, and manage sprawling restaurant empires.

India's Tejas Networks will supply 5G radios to Japan's NEC, a deal signaling a major shift in global supply chains and a win for open network standards.

Huawei's new AI Calling solution promises real-time translation and smart assistants, but can global networks and privacy standards keep up with innovation?

ASUS unveils new liquid-cooling solutions and a partner ecosystem to combat the intense heat of next-gen AI, promising a more sustainable, powerful future.

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

Intapp's new agentic AI platform, Celeste, promises to automate complex workflows while enforcing strict compliance, tackling AI's biggest hurdle in regulated industries.

The insurance distributor posted stellar 2025 results, announcing a massive share buyback and new acquisitions to fuel its aggressive growth strategy.

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

Amid record financials and new AI breakthroughs, Cadence's CEO will address investors at a key conference to outline the firm's pivotal role in the AI era.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

With a booming subscription business and a focus on AI, Arlo Technologies is set to outline its future vision for the competitive smart home security market.

With stellar clinical data and a full war chest, Terns is hitting the road to convince investors its leukemia drug, TERN-701, is a true disruptor.